Atlanta, Georgia
CNS clinical trials in Atlanta, GA
90 CNS studies are recruiting participants at sites in Atlanta as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Atlanta at a glance
- 90 studies are recruiting at a site in Atlanta.
- By phase: Early Phase 1 (2), Phase 1 (2), Phase 2 (19), Phase 3 (38), Phase 4 (7), No phase (16), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (63), university, hospital or other (27).
- By research area: Depression (32), Schizophrenia (19), Multiple Sclerosis (10), Parkinson's Disease (9), Migraine (7), Bipolar Disorder (5), ADHD (4), Epilepsy (4).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Atlanta
Basic details from each study's public record (the 30 most recently updated of 90). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Cenexel Atlanta (ACMR)
- Registry record
- NCT07226661 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- Emory University
- Registry record
- NCT07002034 · updated
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Seaport Therapeutics
- Study site
- Seaport Investigator Site
- Registry record
- NCT07065240 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- CenExel - Atlanta Center for Medical Research
- Registry record
- NCT07592689 · updated
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- No phase
- Ages 22 to 85
- All sexes
- Sponsor
- Motif Neurotech, Inc.
- Study site
- Emory Healthcare
- Registry record
- NCT07594483 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- Emory University
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Emory Saint Joseph's Hospital · Emory University Hospital Midtown · Emory University Hospital/Winship Cancer Institute
- Registry record
- NCT06748222 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- The Emory Clinic
- Registry record
- NCT05850689 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- CenExeli Research LLC
- Registry record
- NCT06372964 · updated
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Agile Clinical Research Trials, LLC
- Registry record
- NCT06559306 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Peachford Hospital-Atlanta Behavioral Research
- Registry record
- NCT07227454 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Agile Clinical Research Trials, LLC
- Registry record
- NCT07573176 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Atlanta, GA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Atlanta
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- Minerva Neurosciences
- Study site
- Atlanta Center for Medical Research, LLC
- Registry record
- NCT07565428 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT07424404 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Atlanta Center for Medical Research · CenExeli Research LLC
- Registry record
- NCT06229210 · updated
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Phase 1
- Ages 18 to 60
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Synexus Clinical Research US Inc
- Registry record
- NCT07615426 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Atlanta, GA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Atlanta
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT06951711 · updated
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Atlanta Center for Medical Research
- Registry record
- NCT07286175 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Atlanta, GA on ClinicalTrials.gov.
ADHD studies recruiting in Atlanta
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Emory University (Children's Healthcare of Atlanta)
- Registry record
- NCT03047369 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Atlanta, GA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Atlanta
Adaptango Performance PRocess for Older Adults Community reHabilitation
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Emory University
- Study site
- Emory University, Executive Park, Wesley Woods
- Registry record
- NCT07824128 · updated
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Winship Cancer Institute of Emory University ( Site 5005)
- Registry record
- NCT07216703 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Grady Memorial Hospital
- Registry record
- NCT07174310 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Atlanta, GA on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Atlanta
Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Shepherd Center, Atlanta GA
- Study site
- Shepherd Center
- Registry record
- NCT07927439 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Atlanta, GA on ClinicalTrials.gov.
Epilepsy studies recruiting in Atlanta
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Registry record
- NCT07563881 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study sites
- Children's Healthcare of Atlanta · Emory Brain Health Center
- Registry record
- NCT05667142 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Atlanta, GA on ClinicalTrials.gov.
Migraine studies recruiting in Atlanta
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Clinical Integrative Research Center of Atlanta
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Clinical Integrative Research Center of Atlanta
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Atlanta, GA on ClinicalTrials.gov.
Ask about studies near Atlanta
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Georgia
All Georgia locations
139 studies recruiting across 23 cities.
Decatur
33 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections